Erratum: Cushing's syndrome caused by an occult source: Difficulties in diagnosis and management (Nature Clinical Practice Endocrinology and Metabolism (2006) 2, (642-647) DOI: 10.1038/ncpendmet0327);Cushing's syndrome caused by an occult source: Difficulties in diagnosis and management

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 11, 2006, Pages 642-647

  Grossman, Ashley B ^a,f   Kelly, Philip ^b   Rockall, Andrea ^c   Bhattacharya, Satya ^d   McNicol, Ann ^e   Balwick, Tara ^a  

^a Department of Neuroendocrinology ^*

^b Centre for Endocrinology   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

^f ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Carcinoid tumor; Cushing's syndrome; Ectopic ACTH syndrome; Neuroendocrine tumor; Therapy

Indexed keywords

CONTRACEPTIVE AGENT; FUROSEMIDE; GLUCOCORTICOID; MINERALOCORTICOID; SPIRONOLACTONE;

ACNE; ADULT; ANKLE EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; FEMALE; GASTROSCOPY; HIRSUTISM; HUMAN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL EDEMA; PRIORITY JOURNAL; SCINTIGRAPHY; WEIGHT GAIN;

EID: 33750606098     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0387     Document Type: Erratum

References (18)

1. Nieman LK (2006) Difficulty in the diagnosis of Cushing disease. Nat Clin Pract Endocrinol Metab 2: 53-57
2. Newell-Price J et al. (2006) Cushing's syndrome. Lancet 367: 1605-1617
3. Newell-Price J et al. (1998) The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 19: 647-672
4. Bader TR et al. (2001) MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver. J Magn Reson Imaging 14: 261-269
5. Isidori AM et al. (2006) The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 91: 371-377
6. Ilias I et al. (2005) Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 90: 4955-4962
7. Pacak K et al. (2004) Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 25: 568-580
8. 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. Clin Endocrinol (Oxf) 64: 371-374
9. Isidori AM et al. (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 88: 5299-5306
10. Woo YS et al. (2005) Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. J Clin Endocrinol Metab 90: 4963-4969
11. Kaltsas GA et al. (1999) A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 84: 487-492
12. Kelly PA et al. (2002) Neurosurgical treatment of Nelson's syndrome. J Clin Endocrinol Metab 87: 5465-5469
13. Jeffcoate WJ et al. (1977) Metyrapone in long-term management of Cushing's disease. Br Med J 2: 215-217
14. Carey RM et al. (1973) Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis. J Clin Endocrinol Metab 36: 482-487
15. Drake WM et al. (1998) Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. J Clin Endocrinol Metab 83: 3542-3544
16. Greening JE et al. (2005) Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease. Horm Res 64: 140-143
17. Zografos GN et al. (2006) Laparoscopic surgery for adrenal tumors. A retrospective analysis. Hormones (Athens) 5: 52-56
18. Jackman DM and Johnson BE (2005) Small-cell lung cancer. Lancet 366: 1385-1396